Sunshine Metals /Australi (SHN.AX) traded down -4.17 % during a 24 hours period ending at 04:29 PM Central Europe on Monday 26th. One Sunshine Metals /Australi stock can currently be bought for about AUD 0.02 on popular exchanges. Current supply of Sunshine Metals /Australi stocks is 3.6 bn. Sunshine Metals /Australi has a current market capitalization of AUD 82.8 mn and approximately AUD 215.4 k worth of Sunshine Metals /Australi was traded on exchanges in the last 24 hours. Since last month end, Sunshine Metals /Australi has traded -37.84 % down. Simple moving average of last 200 days is at AUD 0.03. The highest price of past 52 weeks was recorded at AUD 0.05 on 02/25/2026. 52 weeks low was at AUD 0.02 on 12/19/2025.
Here is how related stocks have performed in the past 24 hours:
Sports Entertainment L (SEG.AX) traded flat 0 % and now trades at AUD 0.28. Sports Entertainment L has a market capitalisation of AUD 94.3 mn. Sports Entertainment L has a current price to earnings ratio of 42.42.
Geopacific (GPR.AX) traded up 11.11 % and now trades at AUD 0.02. Geopacific has a market capitalisation of AUD 96.8 mn. GEOPACIFIC RESOURCES LTD announced its upcoming annual general meeting, scheduled for 25 November 2026, where shareholders will vote on several key corporate matters. The company will present its annual financial report and related documents, including the remuneration report and auditor’s statement. Shareholders will consider the re‑election of director Scott Williamson and the election of newly appointed directors Warrick Clent and Rob Curtis, both of whom bring extensive mining and exploration experience. The board will seek approval for a 7.1A mandate, allowing the company to issue additional equity securities without further shareholder consent, subject to a 75% affirmative vote. Additionally, shareholders will vote on the issuance of zero‑exercise price options to several directors, a move intended to align executive incentives with shareholder interests. No other material business is proposed at this meeting.
Energy Transition Minerals L (ETM.AX) traded down -2.22 % and now trades at AUD 0.05. Energy Transition Minerals L has a market capitalisation of AUD 97.4 mn. Energy Transition Minerals Ltd reported its September 2026 quarter as a period of significant progress across its portfolio. The company completed the acquisition of the Penouta tin‑tantalum‑niobium mine and processing facility in north‑west Spain, transferring ownership to its wholly‑owned Spanish subsidiary. Work on the new Section C exploitation concession was advanced, with updated technical, environmental and social impact studies prepared in anticipation of a potential restart. Parallel technical studies for a scoping and pre‑feasibility assessment were also progressed, focusing on resource planning, plant performance, tailings design and community engagement. Legal proceedings continue over the Kvanefjeld rare‑earth project in Greenland, with a high‑court decision directing the timing of further submissions. In Canada, exploration licences in James Bay remain in good standing, with no on‑ground activity reported. The company’s cash position declined modestly during the quarter, reflecting investment in asset development and ongoing financing activities.
Dxn (DXN.AX) traded down -7.27 % and now trades at AUD 0.26. Dxn has a market capitalisation of AUD 94 mn.
Island (ILA.AX) traded up 1.56 % and now trades at AUD 0.31. Island has a market capitalisation of AUD 96.2 mn. Island Pharmaceuticals Limited reported progress on its Galidesivir program during the quarter ended 30 September 2026. The company secured government and regulatory approvals for compassionate use of Galidesivir in patients affected by the Bundibugyo Ebola outbreak in Uganda, creating an opportunity to gather prospective human data. A dose‑optimisation study with Texas Biomedical Research Institute was launched, complementing a similar programme at USAMRIID; together these studies aim to strengthen the evidence package for the FDA Animal Rule pathway for Marburg virus disease. Manufacturing activity continued with a second GMP‑grade Galidesivir campaign, expanding the inventory to support outbreak response and future studies. The company also obtained a Singapore patent covering ISLA‑101 for flavivirus treatment, broadening its intellectual‑property portfolio. Financially, the company ended the quarter with cash and equivalents of about $7.8 million. Operating cash outflows were largely driven by research and development, manufacturing and regulatory activities, while financing cash flow was modest, reflecting option exercise proceeds. Overall, Island is advancing multiple development tracks and expanding its manufacturing and regulatory foundations for Galidesivir and ISLA‑101.
About Sunshine Metals /Australi
Sunshine Metals Ltd-Australia is a materials and mining company that offers exploration and mining services. The company is located in Garbutt, Australia, and operates in the Queensland region, where it explores and develops gold, copper, zinc, and molybdenum assets. Sunshine Metals serves customers exclusively in Australia. The official website for the company is www.shnmetals.com.au , and it trades on the ASX All Markets stock exchange.
